Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.

Rybakowski JK.

CNS Drugs. 2013 Mar;27(3):165-73. doi: 10.1007/s40263-013-0040-7. Review.

2.

Response to lithium in bipolar disorder: clinical and genetic findings.

Rybakowski JK.

ACS Chem Neurosci. 2014 Jun 18;5(6):413-21. doi: 10.1021/cn5000277. Epub 2014 Mar 25. Review.

3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

Factors associated with lithium efficacy in bipolar disorder.

Rybakowski JK.

Harv Rev Psychiatry. 2014 Nov-Dec;22(6):353-7. doi: 10.1097/HRP.0000000000000006. Review.

PMID:
25377609
5.

[Mood stabilizers--past, present and future].

Sümegi A.

Neuropsychopharmacol Hung. 2008 Mar;10(1):31-42. Review. Hungarian.

6.

[Predictors of prophylactic response to lithium].

Rohayem J, Baylé JF, Richa S.

Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Review. French.

PMID:
18922242
7.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Cipriani A, Reid K, Young AH, Macritchie K, Geddes J.

Cochrane Database Syst Rev. 2013 Oct 17;(10):CD003196. doi: 10.1002/14651858.CD003196.pub2. Review.

PMID:
24132760
8.

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

Smith LA, Cornelius V, Warnock A, Bell A, Young AH.

Bipolar Disord. 2007 Jun;9(4):394-412. Review.

PMID:
17547586
9.

[Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?].

Bánki CM.

Psychiatr Hung. 2007;22(4):311-20. Review. Hungarian.

PMID:
18167425
10.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

11.

Can the response to mood stabilizers be predicted in bipolar disorder?

Geoffroy PA, Bellivier F, Leboyer M, Etain B.

Front Biosci (Elite Ed). 2014 Jan 1;6:120-38. Review.

12.

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.

Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK.

Mol Psychiatry. 2004 Aug;9(8):734-55. Review.

PMID:
15136794
13.

Evolving trends in the long-term treatment of bipolar disorder.

Vieta E, Rosa AR.

World J Biol Psychiatry. 2007;8(1):4-11. Review.

PMID:
17366344
14.

Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.

Alda M.

Mol Psychiatry. 2015 Jun;20(6):661-70. doi: 10.1038/mp.2015.4. Epub 2015 Feb 17. Review.

15.

Molecular actions and clinical pharmacogenetics of lithium therapy.

Can A, Schulze TG, Gould TD.

Pharmacol Biochem Behav. 2014 Aug;123:3-16. doi: 10.1016/j.pbb.2014.02.004. Epub 2014 Feb 15. Review.

16.

Long-term pharmacological treatment of bipolar disorders.

Rybakowski J.

Neuro Endocrinol Lett. 2007 Feb;28 Suppl 1:71-93. Review.

PMID:
17262006
17.

Pediatric bipolar disorder: evidence-based psychopharmacological treatments.

Hamrin V, Pachler M.

J Child Adolesc Psychiatr Nurs. 2007 Feb;20(1):40-58. Review.

PMID:
17284237
18.

Maintenance therapies in bipolar disorder: focus on randomized controlled trials.

Muzina DJ, Calabrese JR.

Aust N Z J Psychiatry. 2005 Aug;39(8):652-61. Review.

PMID:
16050919
19.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM.

Cochrane Database Syst Rev. 2001;(3):CD003196. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD003196.

PMID:
11687047
20.

Treatment-refractory bipolar disorder: classification to aid in clinical management.

Gajwani P.

Expert Opin Pharmacother. 2009 Aug;10(12):1907-15. doi: 10.1517/14656560903064170. Review.

PMID:
19606936

Supplemental Content

Support Center